Tumor or breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Axilla Mammary Glands, Human Neoplastic Stem Cells Lymph Nodes Neoplastic Cells, Circulating Cell Line Nipples Epithelial Cells Mammary Glands, Animal

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Transgenic Mice, Inbred C57BL

Diseases53

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasm Metastasis Breast Diseases Neoplasm Invasiveness Mammary Neoplasms, Experimental Breast Neoplasms, Male Ovarian Neoplasms Carcinoma, Lobular Neoplasm Recurrence, Local Lymphatic Metastasis Neoplasms Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Disease Progression Neoplasms, Hormone-Dependent Colonic Neoplasms Carcinoma Lung Neoplasms Adenocarcinoma Bone Neoplasms Neovascularization, Pathologic Cell Transformation, Neoplastic Neoplasms, Experimental Fibrocystic Breast Disease Pancreatic Neoplasms Brain Neoplasms Stomach Neoplasms Wilms Tumor Prostatic Neoplasms Carcinoma, Ductal Carcinoma in Situ Carcinoma, Squamous Cell Mammary Neoplasms, Animal Neoplasms, Second Primary Carcinoid Tumor Liver Neoplasms Neoplastic Cells, Circulating Triple Negative Breast Neoplasms Neuroendocrine Tumors Skin Neoplasms Neoplasms, Multiple Primary Inflammatory Breast Neoplasms Urinary Bladder Neoplasms Uterine Cervical Neoplasms Neoplasms, Radiation-Induced Fibroadenoma Disease Models, Animal Kidney Neoplasms Carcinoma, Non-Small-Cell Lung Endometrial Neoplasms Neoplasms, Basal Cell Precancerous Conditions

Chemicals and Drugs55

Receptors, Estrogen Tumor Markers, Biological Receptor, erbB-2 Tamoxifen Receptors, Progesterone Neoplasm Proteins Antineoplastic Agents, Hormonal Antineoplastic Agents Tumor Suppressor Protein p53 RNA, Messenger Tumor Necrosis Factor-alpha Tumor Suppressor Proteins Estrogen Receptor alpha DNA, Neoplasm Estrogens BRCA1 Protein Antigens, Neoplasm BRCA2 Protein Antibodies, Monoclonal RNA, Small Interfering Estrogen Antagonists Aromatase Inhibitors Fluorouracil Estradiol Antibodies, Monoclonal, Humanized Cyclophosphamide Cancer Vaccines RNA, Neoplasm Ki-67 Antigen Estrogen Receptor Modulators Epirubicin Nitriles Selective Estrogen Receptor Modulators Paclitaxel Transcription Factors DNA-Binding Proteins Anticarcinogenic Agents Mucin-1 Antibiotics, Antineoplastic Proto-Oncogene Proteins MicroRNAs Antigens, CD24 Receptor, Epidermal Growth Factor Doxorubicin Proto-Oncogene Proteins c-akt Triazoles Cisplatin Carcinogens DNA Primers Radiopharmaceuticals Cyclin D1 Protein-Serine-Threonine Kinases Anthracyclines Cadherins Quinazolines

Analytical, Diagnostic and Therapeutic Techniques and Equipment76

Mammography Prognosis Tumor Burden Neoplasm Staging Mammary Neoplasms, Experimental Risk Factors Mastectomy Early Detection of Cancer Chemotherapy, Adjuvant Survival Analysis Antineoplastic Combined Chemotherapy Protocols Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Disease-Free Survival Xenograft Model Antitumor Assays Case-Control Studies Survival Rate Follow-Up Studies Transplantation, Heterologous Retrospective Studies Treatment Outcome Risk Breast Self-Examination Blotting, Western Prospective Studies Risk Assessment Neoplasms, Experimental Neoplasm Transplantation Mastectomy, Segmental Incidence Odds Ratio Sensitivity and Specificity Oligonucleotide Array Sequence Analysis Combined Modality Therapy Multivariate Analysis Transfection Cohort Studies Immunoenzyme Techniques Kaplan-Meier Estimate Polymerase Chain Reaction Registries Predictive Value of Tests Ultrasonography, Mammary Reproducibility of Results Neoplasm Grading SEER Program Logistic Models Radiotherapy, Adjuvant Questionnaires Tissue Array Analysis Neoadjuvant Therapy Breast Implants Biopsy Clinical Trials as Topic Biopsy, Needle In Situ Hybridization, Fluorescence Radiotherapy Models, Biological Gene Knockdown Techniques Drug Administration Schedule Flow Cytometry Mass Screening Proportional Hazards Models Confidence Intervals Tumor Stem Cell Assay Mammaplasty Disease Models, Animal DNA Mutational Analysis Genetic Testing Lymph Node Excision Sentinel Lymph Node Biopsy Drug Screening Assays, Antitumor Molecular Targeted Therapy Estrogen Replacement Therapy Tomography, X-Ray Computed

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes50

Gene Expression Regulation, Neoplastic Cell Proliferation Genes, BRCA1 Postmenopause Genes, Tumor Suppressor Genetic Predisposition to Disease Premenopause Breast Feeding Drug Resistance, Neoplasm Signal Transduction Mutation Risk Cell Division Time Factors Menopause Genes, BRCA2 Tumor Microenvironment Cell Movement Apoptosis Odds Ratio Sensitivity and Specificity Genes, erbB-2 Transfection Down-Regulation Cell Growth Processes Promoter Regions, Genetic Dose-Response Relationship, Drug DNA Methylation Cell Survival Cell Cycle Germ-Line Mutation Genotype Up-Regulation Gene Amplification Gene Expression Base Sequence RNA Interference Genes, p53 Polymorphism, Genetic Phenotype Gene Silencing Phosphorylation Genes, Neoplasm Loss of Heterozygosity Drug Synergism Epithelial-Mesenchymal Transition Alleles Parity Transcription, Genetic Heterozygote

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries Base Sequence SEER Program Molecular Sequence Data Questionnaires

Named Groups2

Survivors European Continental Ancestry Group

Health Care30

Risk Factors Survival Analysis Disease-Free Survival Case-Control Studies Survival Rate Follow-Up Studies Retrospective Studies Treatment Outcome Risk Prospective Studies Risk Assessment Age Factors Incidence Odds Ratio Sensitivity and Specificity Multivariate Analysis Cohort Studies Kaplan-Meier Estimate Registries Predictive Value of Tests Reproducibility of Results SEER Program Logistic Models Questionnaires Clinical Trials as Topic Mass Screening Proportional Hazards Models Confidence Intervals Genetic Testing Parity

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Breast Breast Neoplasms Cell Line, Tumor Carcinoma, Ductal, Breast Receptors, Estrogen Tumor Markers, Biological Neoplasm Metastasis Breast Diseases Receptor, erbB-2 Gene Expression Regulation, Neoplastic Tamoxifen Receptors, Progesterone Mammography Prognosis Tumor Burden Neoplasm Staging Neoplasm Proteins Neoplasm Invasiveness Mammary Neoplasms, Experimental Antineoplastic Agents, Hormonal Breast Neoplasms, Male Antineoplastic Agents Mice, Nude Cell Proliferation Risk Factors Mastectomy Early Detection of Cancer Chemotherapy, Adjuvant Ovarian Neoplasms Survival Analysis Carcinoma, Lobular Tumor Suppressor Protein p53 Genes, BRCA1 Postmenopause Antineoplastic Combined Chemotherapy Protocols Immunohistochemistry Neoplasm Recurrence, Local RNA, Messenger Lymphatic Metastasis Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Neoplasms Carcinoma, Intraductal, Noninfiltrating MCF-7 Cells Genes, Tumor Suppressor Disease-Free Survival Genetic Predisposition to Disease Xenograft Model Antitumor Assays Tumor Necrosis Factor-alpha Case-Control Studies Tumor Suppressor Proteins Disease Progression Survival Rate Follow-Up Studies Transplantation, Heterologous Estrogen Receptor alpha DNA, Neoplasm Neoplasms, Hormone-Dependent Estrogens Retrospective Studies Premenopause Breast Feeding Treatment Outcome Tumor Cells, Cultured Drug Resistance, Neoplasm Signal Transduction Colonic Neoplasms Mutation Risk Carcinoma Cell Division Lung Neoplasms Breast Self-Examination Time Factors Blotting, Western Prospective Studies Adenocarcinoma Bone Neoplasms Neovascularization, Pathologic Menopause Cell Transformation, Neoplastic BRCA1 Protein Antigens, Neoplasm BRCA2 Protein Risk Assessment Genes, BRCA2 Tumor Microenvironment Neoplasms, Experimental Age Factors Cell Movement Antibodies, Monoclonal Apoptosis RNA, Small Interfering Estrogen Antagonists Aromatase Inhibitors Fibrocystic Breast Disease Neoplasm Transplantation Mastectomy, Segmental Incidence Survivors

No FAQ available that match "tumor or breast cancer"